Insider holders · CIK 0001855175
Contineum Therapeutics, Inc. · CTNM
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Daniel S. LorrainChief Scientific Officer | 135,202 | 10,110 | 145,312 | Jul 10, 2026 · 5:20 pm EDT | Form 4 |
| Carmine N. StengoneCEO and President | 17,217 | — | 17,217 | Sep 8, 2026 · 6:08 pm EDT | Form 4 |
| Tim WatkinsCMO & Head of Development | 8,961 | — | 8,961 | Jul 1, 2026 · 7:04 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.